The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The archive — 2024
Page 17 of 68 of this archive, newest first.
What we would need to randomise to answer this properly
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
Japan pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
CPC declines, for the 23rd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
France declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Calder Vale Peptides of Skipton closes after 16 years
A proper account of an operation that existed, and of what closing it cost.
Escalating onto a rising curve
We work the arithmetic out in full, because it is arithmetic and it is short.
What the four services actually offer, test by test
Endotoxin is the more tractable of the two questions, and a kinetic chromogenic determination is neither slow nor exotic. It is simply not on the menu.
What the new Japan guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What changed at CPC in October, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Medutest result on a Xi'an semaglutide lot lands 3.3 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The dose that got you here and the dose that keeps you here
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
Hydration, protein and the two failures that compound each other
Almost nothing in the standard management repertoire has been tested in a randomised trial in this specific population. We say what is extrapolated and from where.
A supplier suspends shipping to Nigeria after 14 consecutive customs detentions
The route did not close because of a rule about peptides.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
From the floor in Changsha: 21 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Side effects, cost, supply, target: four reasons with four trajectories
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
Set the threshold at a tenth of a per cent and the small impurities vanish
Baseline placement under a tailing peak is a judgement call with a direct effect on the area. It is one of the few places where two competent analysts genuinely disagree.
The 13-day notice: how a compounding wind-down works in Argentina
The document is four pages. Three of them are about dates.
Inspectors cite Calder Vale Peptides of Skipton over sterility assurance
The observation that closes a facility is rarely the dramatic one.
Nigeria caps liraglutide prescribing to 21 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
LEADER extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Six words a verification badge would need to mean anything
Every step between the laboratory report and the product page removes information, and the badge is the last step.
Repackaging, subdivision, and the batch number that changed hands
The interval between manufacture and analysis is the most under-read figure on the page, and the one most likely to matter by the time a vial is opened.
The one randomised trial that combined an incretin with supervised exercise
One randomised trial has combined a GLP-1 receptor agonist with supervised exercise. Its result is the single most useful piece of evidence in this area.
A shortage listing ends. 11 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.
Independent analysis puts a TFC tirzepatide lot at 97.7%, against 95.0% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
SSA declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.